OxyContin, an extended-release oxycodone formulation, is a Schedule II controlled substance under the U.S. Controlled Substances Act, requiring a valid prescription from a DEA-registered provider only for opioid-tolerant patients with chronic pain unresponsive to alternatives. No refills allowed, with states often capping initial supplies at 7 days and mandating PDMP checks.
Providers assess tolerance (minimum 20 mg/day oxycodone equivalent) via in-person or telehealth before issuing non-refillable scripts starting at 10 mg every 12 hours, with slow titration. Submit to NABP-verified pharmacies for secure dispensing; legitimate sites verify prescriptions strictly.
Sites claiming "no prescription" sales violate federal law, selling counterfeits with high overdose risk due to tampering potential. Misuse leads to addiction, respiratory failure, or death; FDA mandates REMS education.
Our mission is to empower patients with information and support, fund groundbreaking LMS research and provide a bridge between patients and researchers, to collaborate on finding a cure.
| Supporters | |||
| Name | Date | Amount | Comments |
| Total | $0.00 | ||